{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:42:10Z","timestamp":1761514930642,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1156444"],"award-info":[{"award-number":["GNT1156444"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020982","name":"Arvelle Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020982","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.yebeh.2022.108883","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T13:02:02Z","timestamp":1661259722000},"page":"108883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Identification of factors associated with new-onset vascular disease in patients admitted for video-EEG monitoring: A longitudinal cohort study"],"prefix":"10.1016","volume":"135","author":[{"given":"John-Paul","family":"Nicolo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhibin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell","family":"Nightscales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence J.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2022.108883_b0005","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1212\/WNL.0000000000002984","article-title":"Excess mortality and hospitalized morbidity in newly treated epilepsy patients","volume":"87","author":"Chen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2022.108883_b0010","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/pds.2186","article-title":"Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction, stroke, and death in patients with or without previous stroke: a nationwide cohort study","volume":"20","author":"Olesen","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.yebeh.2022.108883_b0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.yebeh.2018.09.009","article-title":"Myocardial infarction after epilepsy onset: a population-based retrospective cohort study","volume":"88","author":"Wilson","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108883_b0020","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1093\/brain\/awp216","article-title":"Increased risk and worse prognosis of myocardial infarction in patients with prior hospitalization for epilepsy\u2014the Stockholm Heart Epidemiology Program","volume":"132","author":"Janszky","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2022.108883_b0025","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/epi.16930","article-title":"Epilepsy, antiepileptic drugs, and the risk of major cardiovascular events","volume":"62","author":"Lee-Lane","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108883_b0030","doi-asserted-by":"crossref","first-page":"106307","DOI":"10.1016\/j.yebeh.2019.05.005","article-title":"Increased risk of stroke and myocardial infarction in patients with epilepsy: a systematic review of population-based cohort studies","volume":"104","author":"Brigo","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108883_b0035","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/jnnp.47.3.225","article-title":"Evidence of vascular disease from CT scanning in late onset epilepsy","volume":"47","author":"Shorvon","year":"1984","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2022.108883_b0040","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1528-1157.1988.tb04418.x","article-title":"Clinically unsuspected cerebral infarction revealed by computed tomography scanning in late onset epilepsy","volume":"29","author":"Roberts","year":"1988","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108883_b0045","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.clineuro.2012.07.009","article-title":"Prevalence and subtypes of radiological cerebrovascular disease in late-onset isolated seizures and epilepsy","volume":"115","author":"Maxwell","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.yebeh.2022.108883_b0050","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/cns.12571","article-title":"White matter hyperintensities on brain magnetic resonance imaging in people with epilepsy: a hospital-based study","volume":"22","author":"Mao","year":"2016","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.yebeh.2022.108883_b0055","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1111\/epi.16966","article-title":"Epileptic heart: A clinical syndromic approach","volume":"62","author":"Verrier","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108883_b0060","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11940-010-0080-y","article-title":"Antiepileptic drugs and markers of vascular risk","volume":"12","author":"LoPinto-Khoury","year":"2010","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.yebeh.2022.108883_b0065","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/j.1528-1167.2009.02024.x","article-title":"Long-term antiepileptic drug therapy contributes to the acceleration of atherosclerosis","volume":"50","author":"Tan","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108883_b0070","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jamaneurol.2021.3424","article-title":"Association of enzyme-inducing antiseizure drug use with long-term cardiovascular disease","volume":"78","author":"Josephson","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.yebeh.2022.108883_b0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.eplepsyres.2007.11.005","article-title":"Increased oxidative stress in epileptic children treated with valproic acid","volume":"78","author":"Verrotti","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2022.108883_b0080","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2353\/ajpath.2009.080385","article-title":"Valproate attenuates accelerated atherosclerosis in hyperglycemic apoE-deficient mice: evidence in support of a role for endoplasmic reticulum stress and glycogen synthase kinase-3 in lesion development and hepatic steatosis","volume":"174","author":"Bowes","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.yebeh.2022.108883_b0085","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.0013-9580.2004.51003.x","article-title":"Evaluating the utility of inpatient video-EEG monitoring","volume":"45","author":"Ghougassian","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108883_b0090","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/PSY.0b013e3181d96550","article-title":"Clinical characteristics and outcome in patients with psychogenic nonepileptic seizures","volume":"72","author":"Jones","year":"2010","journal-title":"Psychosom Med"},{"key":"10.1016\/j.yebeh.2022.108883_b0095","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1212\/WNL.0000000000006776","article-title":"Sleep-disordered breathing among patients admitted for inpatient video-EEG monitoring","volume":"92","author":"Sivathamboo","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2022.108883_b0100","doi-asserted-by":"crossref","first-page":"e643","DOI":"10.1212\/WNL.0000000000009855","article-title":"Mortality in patients with psychogenic nonepileptic seizures","volume":"95","author":"Nightscales","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2022.108883_b0105","doi-asserted-by":"crossref","first-page":"e1051","DOI":"10.1212\/WNL.0000000000009061","article-title":"Antiepileptic drugs are not independently associated with cognitive dysfunction","volume":"94","author":"Foster","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2022.108883_b0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1528-1167.2012.03671.x","article-title":"Enzyme induction with antiepileptic drugs: cause for concern?","volume":"54","author":"Brodie","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108883_b0115","unstructured":"Australian Bureau of Statistics. Census of population and housing: socio-economic indexes for areas (SEIFA) A, 2016. Cat. no. 2033.0.55.001. Available at: https:\/\/www.abs.gov.au\/ausstats\/abs@.nsf\/Lookup\/by%20Subject\/2033.0.55.001~2016~Main%20Features~IRSAD%20Interactive%20Map~16. Accessed September 2, 2020."},{"key":"10.1016\/j.yebeh.2022.108883_b0120","unstructured":"Australian Bureau of Statistics. Death A, 2018. Cat. no. 3302.0. Available at: abs.gov.au\/AUSSTATS\/abs@.nsf\/DetailsPage\/3302.02018?OpenDocument. Accessed September 2, 2020."},{"key":"10.1016\/j.yebeh.2022.108883_b0125","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fneur.2017.00180","article-title":"stroke incidence in Victoria, Australia\u2014emerging improvements","volume":"8","author":"Clissold","year":"2017","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2022.108883_b0130","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.yebeh.2022.108883_b0135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrcardio.2017.189","article-title":"Effects of stress on the development and progression of cardiovascular disease","volume":"15","author":"Kivim\u00e4ki","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.yebeh.2022.108883_b0140","doi-asserted-by":"crossref","first-page":"108582","DOI":"10.1016\/j.yebeh.2022.108582","article-title":"Functional seizures are associated with cerebrovascular disease and functional stroke is more common in patients with functional seizures than epileptic seizures","volume":"128","author":"Fox","year":"2022","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108883_b0145","doi-asserted-by":"crossref","first-page":"107878","DOI":"10.1016\/j.yebeh.2021.107878","article-title":"Cardiovascular disease risk, awareness, and treatment in people with epilepsy","volume":"117","author":"Terman","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108883_b0150","unstructured":"Australian Bureau of Statistics. National Health Survey: First Results 2017-18. Available at: https:\/\/www.abs.gov.au\/statistics\/health\/health-conditions-and-risks\/national-health-survey-first-results\/latest-release. Accessed October 2, 2020."},{"key":"10.1016\/j.yebeh.2022.108883_b0155","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.yebeh.2007.12.001","article-title":"Health status and behavioral risk factors among persons with epilepsy in Ohio based on the 2006 Behavioral Risk Factor Surveillance System","volume":"12","author":"Elliott","year":"2008","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108883_b0160","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0140-6736(09)61037-0","article-title":"Adverse health effects of non-medical cannabis use","volume":"374","author":"Hall","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2022.108883_b0165","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.yebeh.2019.05.037","article-title":"Marijuana use among patients with epilepsy at a tertiary care center","volume":"97","author":"Kerr","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108883_b0170","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/pds.2073","article-title":"Valproate attenuates the risk of myocardial infarction in patients with epilepsy: a nationwide cohort study","volume":"20","author":"Olesen","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.yebeh.2022.108883_b0175","doi-asserted-by":"crossref","unstructured":"Dregan A, Charlton J, Wolfe CD, Gulliford MC, Markus HS. Is sodium valproate, an HDAC inhibitor, associated with reduced risk of stroke and myocardial infarction? A nested case\u2013control study. Pharmacoepidemiol Drug Saf 2014;23:759-767.","DOI":"10.1002\/pds.3651"},{"key":"10.1016\/j.yebeh.2022.108883_b0180","doi-asserted-by":"crossref","first-page":"e008365","DOI":"10.1136\/bmjopen-2015-008365","article-title":"Antiepileptic drugs and the risk of ischaemic stroke and myocardial infarction: a population-based cohort study","volume":"5","author":"Renoux","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.yebeh.2022.108883_b0185","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/STROKEAHA.117.016674","article-title":"Sodium valproate, a histone deacetylase inhibitor, is associated with reduced stroke risk after previous ischemic stroke or transient ischemic attack","volume":"49","author":"Brookes","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.yebeh.2022.108883_b0190","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1528-1167.2006.00587.x","article-title":"Valproate-associated coagulopathies are frequent and variable in children","volume":"47","author":"Gerstner","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108883_b0195","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/ana.410390506","article-title":"Obesity and endocrine disorders in women taking valproate for epilepsy","volume":"39","author":"Isoj\u00e4rvi","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2022.108883_b0200","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00198-006-0185-z","article-title":"Anti-epileptic medication and bone health","volume":"18","author":"Petty","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.yebeh.2022.108883_b0205","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/01.mlr.0000228018.48783.34","article-title":"Quality of diagnosis and procedure coding in ICD-10 administrative data","volume":"44","author":"Henderson","year":"2006","journal-title":"Med Care"},{"key":"10.1016\/j.yebeh.2022.108883_b0210","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505022003328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505022003328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:47:16Z","timestamp":1761504436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505022003328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":42,"alternative-id":["S1525505022003328"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.108883","relation":{},"ISSN":["1525-5050"],"issn-type":[{"type":"print","value":"1525-5050"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of factors associated with new-onset vascular disease in patients admitted for video-EEG monitoring: A longitudinal cohort study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.108883","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108883"}}